HIF Gene Expression in Cancer Therapy

Denise A. Chan, Adam Krieg, Sandra Turcotte, Amato J. Giaccia

Research output: Chapter in Book/Report/Conference proceedingChapter

22 Citations (Scopus)

Abstract

Tumor hypoxia is a feature common to almost all solid tumors due to malformed vasculature and inadequate perfusion. Tumor cells have evolved mechanisms that allow them to respond and adapt to a hypoxic microenvironment. The hypoxia-inducible transcription factor (HIF) family is comprised of oxygen-sensitive alpha (α) subunits that respond rapidly to decreased oxygen levels and oxygen-insensitive beta (β) subunits. HIF binds to specific recognition sequences in the genome and increases the transcription of genes involved in a variety of metabolic and enzymatic pathways that are necessary for cells to respond to an oxygen-poor environment. The critical role of this family of transcriptional regulators in maintaining oxygen homeostasis is supported by multiple regulatory mechanisms that allow the cell to control the levels of HIF as well as its transcriptional activity. This review will focus on how the transcriptional activity of HIF is studied and how it can be exploited for cancer therapy.

Original languageEnglish (US)
Title of host publicationOxygen Biology and Hypoxia
EditorsHelmut Sies, Bernhard Brune
Pages323-345
Number of pages23
DOIs
StatePublished - Dec 1 2007
Externally publishedYes

Publication series

NameMethods in Enzymology
Volume435
ISSN (Print)0076-6879

Fingerprint

Gene expression
Transcription Factors
Oxygen
Gene Expression
Tumors
Neoplasms
Genes
Therapeutics
Transcription
Metabolic Networks and Pathways
Homeostasis
Perfusion
Cells
Hypoxia
Genome

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Chan, D. A., Krieg, A., Turcotte, S., & Giaccia, A. J. (2007). HIF Gene Expression in Cancer Therapy. In H. Sies, & B. Brune (Eds.), Oxygen Biology and Hypoxia (pp. 323-345). (Methods in Enzymology; Vol. 435). https://doi.org/10.1016/S0076-6879(07)35016-7

HIF Gene Expression in Cancer Therapy. / Chan, Denise A.; Krieg, Adam; Turcotte, Sandra; Giaccia, Amato J.

Oxygen Biology and Hypoxia. ed. / Helmut Sies; Bernhard Brune. 2007. p. 323-345 (Methods in Enzymology; Vol. 435).

Research output: Chapter in Book/Report/Conference proceedingChapter

Chan, DA, Krieg, A, Turcotte, S & Giaccia, AJ 2007, HIF Gene Expression in Cancer Therapy. in H Sies & B Brune (eds), Oxygen Biology and Hypoxia. Methods in Enzymology, vol. 435, pp. 323-345. https://doi.org/10.1016/S0076-6879(07)35016-7
Chan DA, Krieg A, Turcotte S, Giaccia AJ. HIF Gene Expression in Cancer Therapy. In Sies H, Brune B, editors, Oxygen Biology and Hypoxia. 2007. p. 323-345. (Methods in Enzymology). https://doi.org/10.1016/S0076-6879(07)35016-7
Chan, Denise A. ; Krieg, Adam ; Turcotte, Sandra ; Giaccia, Amato J. / HIF Gene Expression in Cancer Therapy. Oxygen Biology and Hypoxia. editor / Helmut Sies ; Bernhard Brune. 2007. pp. 323-345 (Methods in Enzymology).
@inbook{9b45fd832bc4408e87a032c48b6588c8,
title = "HIF Gene Expression in Cancer Therapy",
abstract = "Tumor hypoxia is a feature common to almost all solid tumors due to malformed vasculature and inadequate perfusion. Tumor cells have evolved mechanisms that allow them to respond and adapt to a hypoxic microenvironment. The hypoxia-inducible transcription factor (HIF) family is comprised of oxygen-sensitive alpha (α) subunits that respond rapidly to decreased oxygen levels and oxygen-insensitive beta (β) subunits. HIF binds to specific recognition sequences in the genome and increases the transcription of genes involved in a variety of metabolic and enzymatic pathways that are necessary for cells to respond to an oxygen-poor environment. The critical role of this family of transcriptional regulators in maintaining oxygen homeostasis is supported by multiple regulatory mechanisms that allow the cell to control the levels of HIF as well as its transcriptional activity. This review will focus on how the transcriptional activity of HIF is studied and how it can be exploited for cancer therapy.",
author = "Chan, {Denise A.} and Adam Krieg and Sandra Turcotte and Giaccia, {Amato J.}",
year = "2007",
month = "12",
day = "1",
doi = "10.1016/S0076-6879(07)35016-7",
language = "English (US)",
isbn = "9780123739704",
series = "Methods in Enzymology",
pages = "323--345",
editor = "Helmut Sies and Bernhard Brune",
booktitle = "Oxygen Biology and Hypoxia",

}

TY - CHAP

T1 - HIF Gene Expression in Cancer Therapy

AU - Chan, Denise A.

AU - Krieg, Adam

AU - Turcotte, Sandra

AU - Giaccia, Amato J.

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Tumor hypoxia is a feature common to almost all solid tumors due to malformed vasculature and inadequate perfusion. Tumor cells have evolved mechanisms that allow them to respond and adapt to a hypoxic microenvironment. The hypoxia-inducible transcription factor (HIF) family is comprised of oxygen-sensitive alpha (α) subunits that respond rapidly to decreased oxygen levels and oxygen-insensitive beta (β) subunits. HIF binds to specific recognition sequences in the genome and increases the transcription of genes involved in a variety of metabolic and enzymatic pathways that are necessary for cells to respond to an oxygen-poor environment. The critical role of this family of transcriptional regulators in maintaining oxygen homeostasis is supported by multiple regulatory mechanisms that allow the cell to control the levels of HIF as well as its transcriptional activity. This review will focus on how the transcriptional activity of HIF is studied and how it can be exploited for cancer therapy.

AB - Tumor hypoxia is a feature common to almost all solid tumors due to malformed vasculature and inadequate perfusion. Tumor cells have evolved mechanisms that allow them to respond and adapt to a hypoxic microenvironment. The hypoxia-inducible transcription factor (HIF) family is comprised of oxygen-sensitive alpha (α) subunits that respond rapidly to decreased oxygen levels and oxygen-insensitive beta (β) subunits. HIF binds to specific recognition sequences in the genome and increases the transcription of genes involved in a variety of metabolic and enzymatic pathways that are necessary for cells to respond to an oxygen-poor environment. The critical role of this family of transcriptional regulators in maintaining oxygen homeostasis is supported by multiple regulatory mechanisms that allow the cell to control the levels of HIF as well as its transcriptional activity. This review will focus on how the transcriptional activity of HIF is studied and how it can be exploited for cancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=39749099312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39749099312&partnerID=8YFLogxK

U2 - 10.1016/S0076-6879(07)35016-7

DO - 10.1016/S0076-6879(07)35016-7

M3 - Chapter

C2 - 17998061

AN - SCOPUS:39749099312

SN - 9780123739704

T3 - Methods in Enzymology

SP - 323

EP - 345

BT - Oxygen Biology and Hypoxia

A2 - Sies, Helmut

A2 - Brune, Bernhard

ER -